Document Detail


Factor V Leiden in central venous catheter-associated thrombosis.
MedLine Citation:
PMID:  12100159     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Subclavian vein thrombosis is a well-recognized complication following central venous catheter insertion and is associated with significant morbidity. The factor V Leiden mutation is an important risk factor for deep venous thrombosis and pulmonary embolism. Whether this mutation also predisposes patients fitted with a central venous catheter to subclavian vein thrombosis is not known. The occurrence of central venous catheter-associated thrombosis was investigated in 277 consecutive patients receiving an allogeneic bone marrow transplantation. All patients received a tunnelled double or triple catheter positioned in the subclavian vein. Catheter-associated thrombosis was diagnosed on the basis of clinical signs of thrombosis, i.e. swelling and/or redness of the limb or venous engorgement and was confirmed with a colour-flow Doppler ultrasound. Thirteen patients were heterozygous for the factor V Leiden mutation. Seven of these patients had a subclavian vein thrombosis (54%), while this occurred in only 9% of the factor V Leiden-negative patients, corresponding with a relative risk of 7.7 (95% CI 3.3-17.9). Factor V Leiden is attributable for 17.3% of all thrombosis in patients with central venous catheters. The majority of patients with the factor V Leiden mutation with a central venous catheter will develop thrombosis. Patients with a factor V Leiden mutation should receive adequate thrombosis prophylaxis upon catheter introduction and the catheter should be removed immediately after the treatment. Based on this very high risk, we advise testing for factor V Leiden in all bone marrow transplantation patients receiving a central venous catheter.
Authors:
Rob Fijnheer; Birgit Paijmans; Leo F Verdonck; H Karel Nieuwenhuis; Mark Roest; Adriaan W Dekker
Related Documents :
12100159 - Factor v leiden in central venous catheter-associated thrombosis.
16858949 - Laboratory approach in thai patients with venous thrombosis.
18282149 - The paradoxical association between inherited factor vii deficiency and venous thrombosis.
8432749 - The hypercoagulable states.
19614999 - Dermal mucinosis as a sign of venous insufficiency.
20651889 - catheter in the superior vena cava for hemodialysis as a last resort in superior hemith...
24015159 - Quantification of vertebral involvement in metastatic spinal disease.
24665309 - Methylmalonic acidemia: diagnosis and neuroimaging findings of this neurometabolic diso...
16133729 - The neurology of cobalamin deficiency in an elderly population in israel.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of haematology     Volume:  118     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  2002 Jul 
Date Detail:
Created Date:  2002-07-08     Completed Date:  2002-09-11     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  England    
Other Details:
Languages:  eng     Pagination:  267-70     Citation Subset:  IM    
Affiliation:
Department of Haematology, University Medical Center Utrecht (UMCU), Utrecht, The Netherlands. R.Fijnheer@azu.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Bone Marrow Transplantation
Catheterization, Central Venous / adverse effects*
Factor V / analysis*
Heterozygote
Humans
Risk Factors
Subclavian Vein*
Thrombosis / blood,  etiology*
Transplantation, Homologous
Chemical
Reg. No./Substance:
0/factor V Leiden; 9001-24-5/Factor V

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A Leu7Pro mutation in the signal peptide of platelet glycoprotein (GP)IX in a case of Bernard-Soulie...
Next Document:  Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old p...